[Federal Register Volume 81, Number 18 (Thursday, January 28, 2016)]
[Notices]
[Page 4930]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-01677]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1117-0034]


Agency Information Collection Activities; Proposed eCollection, 
eComments Requested; Extension Without Change of a Previously Approved 
Collection; Collection of Laboratory Analysis Data on Drug Samples 
Tested by Non-Federal (State and Local Government) Crime Laboratories

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: 30-Day notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Justice (DOJ), Drug Enforcement 
Administration (DEA), will be submitting the following information 
collection request to the Office of Management and Budget (OMB) for 
review and approval in accordance with the Paperwork Reduction Act of 
1995. This proposed information collection was previously published in 
the Federal Register at 80 FR 73834, November 25, 2015, allowing for a 
60-day comment period.

DATES: Comments are encouraged and will be accepted for an additional 
30 days until February 29, 2016.

FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated 
public burden or associated response time, suggestions, or need a copy 
of the proposed information collection instrument with instructions or 
additional information, please contact Barbara J. Boockholdt, Office of 
Diversion Control, Drug Enforcement Administration; Mailing Address: 
8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 
598-6812.
    Written comments and/or suggestions can also be directed to the 
Office of Management and Budget, Office of Information and Regulatory 
Affairs, Attention Department of Justice Desk Officer, Washington, DC 
20530 or sent to [email protected].

SUPPLEMENTARY INFORMATION: Written comments and suggestions from the 
public and affected agencies concerning the proposed collection of 
information are encouraged. Your comments should address one or more of 
the following four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of 
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other forms of information technology, e.g., 
permitting electronic submission of responses.

    Overview of this information collection:
    1. Type of Information Collection: Extension of a currently 
approved collection.
    2. Title of the Form/Collection: Collection of Laboratory Analysis 
Data on Drug Samples Tested by Non-Federal (State and Local Government) 
Crime Laboratories.
    3. The agency form number, if any, and the applicable component of 
the Department sponsoring the collection: There are no applicable forms 
associated with this collection. The applicable component within the 
Department of Justice is the Drug Enforcement Administration, Office of 
Diversion Control.
    4. Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Affected public (Primary): Business or other for-profit.
    Affected public (Other): Not-for-profit institutions; Federal, 
State, local, and tribal governments.
    Abstract: This collection provides the Drug Enforcement 
Administration (DEA) with a national database on analyzed drug evidence 
from non-federal laboratories. Information from this database is 
combined with the other existing databases to develop more accurate, 
up-to-date information on abused drugs. This database represents a 
voluntary, cooperative effort on the part of participating laboratories 
to provide a centralized source of analyzed drug data.
    5. An estimate of the total number of respondents and the amount of 
time estimated for an average respondent to respond: The DEA estimates 
that 140 persons respond annually for this collection at 1.6 hours per 
respondent, for an annual burden of 218 hours.
    6. An estimate of the total public burden (in hours) associated 
with the proposed collection: The DEA estimates that this collection 
takes 218 annual burden hours.
    If additional information is required please contact: Jerri Murray, 
Department Clearance Officer, United States Department of Justice, 
Justice Management Division, Policy and Planning Staff, Two 
Constitution Square, 145 N Street NE., Suite 3E.405B, Washington, DC 
20530.

    Dated: January 25, 2016.
Jerri Murray,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2016-01677 Filed 1-27-16; 8:45 am]
 BILLING CODE 4410-09-P